The Olympic trans athlete policy has taken a dramatic turn with the IOC's announcement that from the Los Angeles 2028 Games, no transgender athlete will be allowed to compete in the female category. The decision, revealed in late March, hinges on a simple genetic test for the SRY gene—a method that has sparked intense debate among scientists, including the very researcher who discovered the gene.
What the IOC's New Trans Athlete Policy Actually Says
The International Olympic Committee has confirmed that starting with the 2028 Los Angeles Olympics, any athlete wishing to compete in the female category must undergo genetic testing for the SRY gene (Sex-determining Region Y). If the gene is present, the athlete will be barred from the female category. The policy marks a significant shift from previous eligibility rules based on testosterone levels.
The announcement follows a similar move by World Athletics, which adopted the same SRY test in September 2025 for its own competitions. Both bodies argue the test provides a clear, objective criterion for determining sex. However, the scientific community remains deeply divided on whether a single gene can accurately define biological sex or athletic advantage.
The SRY Gene: Discovery and Its Limitations
The SRY gene was discovered in 1990 by molecular biologist Andrew Sinclair. It is located on the Y chromosome and is considered a key trigger for male sexual development. Its presence typically indicates a male genetic makeup, but biology is rarely that straightforward.
Sinclair himself has publicly opposed using the SRY gene as a sole determinant for sports eligibility. In an opinion piece, he argued that the test oversimplifies the complex interplay of genetics, hormones, and development. His stance highlights a growing concern: reducing sex to a single gene ignores the spectrum of human biology.
Why the SRY Test Is Scientifically Controversial
Critics point out that the SRY gene is not a perfect proxy for sex. Some individuals with XY chromosomes and the SRY gene may develop as females due to conditions like androgen insensitivity syndrome. Conversely, some XX individuals may have SRY translocated to an X chromosome, leading to male development. These nuances make a binary test problematic.
Moreover, the test does not measure testosterone levels or athletic performance. It simply detects a gene. The IOC's previous policies focused on testosterone thresholds, which are also debated but at least relate to performance. The new approach shifts the focus from physiology to genetics, raising ethical questions about privacy and fairness.
Key Takeaways from the New Policy
- The IOC will require SRY gene testing for female category eligibility starting in 2028.
- World Athletics adopted the same test in September 2025.
- The SRY gene's discoverer, Andrew Sinclair, opposes its use for this purpose.
- Genetic sex is not binary; conditions like androgen insensitivity complicate simple tests.
- The policy may face legal challenges from athletes and advocacy groups.
How the SRY Test Compares to Previous Eligibility Rules
| Aspect | Previous IOC Policy (Testosterone-based) | New SRY Gene Test |
|---|---|---|
| Basis for eligibility | Testosterone levels below 5 nmol/L for 12 months | Absence of SRY gene |
| Scientific rationale | Androgen influence on performance | Genetic sex determination |
| Controversy | Varies by individual, testosterone not sole factor | Oversimplifies biology, ignores spectrum |
| Implementation | Blood tests, monitoring | Genetic swab or blood test |
Who Is Affected by the Olympic Trans Athlete Policy?
The policy directly impacts transgender women, intersex athletes, and anyone with differences in sex development (DSD). It also affects cisgender women who may have unusual genetic profiles. For example, athletes with Complete Androgen Insensitivity Syndrome (CAIS) have XY chromosomes and SRY genes but develop female phenotypes and may have competitive advantages or disadvantages.
Advocacy groups argue that the test invades privacy and could lead to invasive verification processes. They also point out that the policy targets a small number of athletes while sending a broader message about inclusion. The IOC maintains that the policy ensures fair competition, but critics question whether fairness is achieved by excluding those with natural genetic variations. The background to this story is set out in Federal Judge Dismisses Trump Lawsuit on Trans Athletes in California. A related thread runs through Caster Semenya Vows Fight Over IOC Gene Testing Policy. Earlier coverage in Ben Carroll Becomes Victoria's 50th Premier After Dramatic U-Turn shows how the argument developed.
The Future of Sex Testing in Sports
As the 2028 Olympics approach, the SRY test is likely to face legal and scientific scrutiny. Athletes may challenge the policy under anti-discrimination laws, and scientists continue to debate the validity of single-gene testing. The conversation is far from over, and the IOC may need to adapt its approach. A closer look at the same subject appears in England World Cup Heartbreak: Argentina's Dramatic Late Double. Anyone following the wider picture can start with José Mourinho's Real Madrid Return Ends in Dramatic Late Win. The same theme surfaces in Burnley vs West Ham: Flemming's Late Double Secures Dramatic Draw, which takes a different angle.
For now, the decision underscores a fundamental tension between sport's need for clear rules and the complexity of human biology. As Andrew Sinclair's opposition shows, even the discoverer of the gene questions its use as a sole criterion. The world will be watching how this unfolds on the road to Los Angeles. Context on how this played out before sits in Doctors Fight Anti-Trans Genital Exam Rule for Student Athletes. A companion piece, Vollering Wins Tour de France Femmes in Dramatic Finale, approaches the same subject from another angle.
FAQ
What is the SRY gene and why is it used in sports?
The SRY gene is a sex-determining gene on the Y chromosome that triggers male development. Sports bodies use it to verify female eligibility because its presence typically indicates a male genetic profile. However, its use is controversial because genetic sex is not always binary.
Why does Andrew Sinclair oppose the SRY test?
Sinclair, who discovered the gene, argues that the test oversimplifies biology and ignores the complex spectrum of sex development. He believes it is not a reliable sole determinant for athletic eligibility and has publicly spoken out against its use in sports.
How does the new policy affect transgender athletes?
Transgender women who have undergone male puberty and possess the SRY gene will be barred from the female category. The policy effectively excludes them from Olympic competition in that category, regardless of hormone therapy or other factors.
What are the alternatives to the SRY test?
Alternatives include testosterone-based eligibility rules, case-by-case evaluation, or performance-based criteria. Each has its own challenges, but critics argue they may better account for the complexity of sex and fairness in sport.